Evidence shows that TRIM25 is low-expressed in many tumors, including liver cancer, lung cancer, and ovarian cancer, and is closely related to the poor prognosis of tumor patients [33, 35, 36]. Here, TRIM25 is linked to ovarian carcinoma.